Compare ING Groep NV (ING) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ING Groep NV vs Medpace Holdings Inc — how do they compare? ING Groep NV trades at $35.61 (market cap $101.22B), while Medpace Holdings Inc trades at $603.39 (market cap $16.90B). The key difference: ING Groep NV is far larger — about 6× Medpace Holdings Inc's market cap, and ING Groep NV pays a 3.73% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| ING | MEDP | |
|---|---|---|
Market Cap | $101.22B | $16.90B |
Sector | Financials | Technology |
52-Week High | $35.92 | $620.59 |
52-Week Low | $23.66 | $393.42 |
Dividend Yield | 3.73% | — |
Enterprise Value | — | $16.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ING Groep (ING) trades at $35.61, up 1.05% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $0.79 exceeding expectations. Revenue growth remains stable at $22.9B for 2025, supported by a robust 28.34% net income margin and 13.49% ROE. Recent guidance upgrades and strategic acquisitions in wealth management signal management confidence in future growth prospects.
The outlook remains positive with 62.5% analyst buy ratings and technical indicators supporting further upside. Key risks include negative operating cash flows and European banking sector volatility. The stock's attractive 13.24 P/E ratio and dividend yield provide value appeal, though investors should monitor cash flow trends and interest rate sensitivity.
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ING Groep NV
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
